Key facts
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for SOLENO THERAPEUTICS, INC. Common Stock, $0.001 par value (SLNO).
- Disclosed ownership: 5.6%.
- Date of event: 31 Mar 2025.
Nantahala Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for SOLENO THERAPEUTICS, INC. Common Stock, $0.001 par value (SLNO)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- SLNO
- Shares outstanding
- 46,922,339 shares
- Disclosed Ownership
- 2,627,651 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 17:15:20 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Key filing fact
Nantahala Capital Management, LLC disclosed 5.6% ownership in SOLENO THERAPEUTICS, INC. Common Stock, $0.001 par value (SLNO) on 31 Mar 2025.
Change
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 30 Apr 2025, 17:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5.6% | 2,627,651 | 0 | 2,627,651 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 5.6% | 2,627,651 | 0 | 2,627,651 | /s/ Wilmot B. Harkey | Wilmot B. Harkey / Manager | |
| Daniel Mack | 5.6% | 2,627,651 | 0 | 2,627,651 | /s/ Daniel Mack | Daniel Mack / Manager |
CIK / CUSIP context first